Researchers have gained fresh insight into how water interacts with the surface coatings of nanoparticles used for drug delivery, a development that could significantly improve the efficacy of these microscopic carriers. The findings, published this month, detail how these interactions reshape the nanoparticles in biological fluids, impacting their ability to deliver therapeutic payloads.
Nanoparticles are increasingly being explored as a means of delivering drugs directly to diseased tissues, offering the potential to enhance treatment effectiveness and reduce side effects. These systems are designed to improve drug solubility, protect therapeutic agents from degradation within the body, and control the rate at which a drug is released. However, a key challenge lies in ensuring these particles remain stable and functional once introduced into the complex environment of bodily fluids like blood, gut contents, or cerebrospinal fluid, according to a recent review of the field.
The surface properties of nanoparticles – including their charge, hydrophobicity, and the functional groups present – are critical determinants of their behavior in biological systems. These characteristics influence how nanoparticles interact with cells, proteins, and other components of the body, ultimately affecting their stability, uptake by cells, and ability to evade the immune system. Recent advances have focused on surface decoration of nanoparticles to address these challenges, aiming for improved colloidal and biological stability, reduced toxicity, and enhanced drug targeting.
The new research highlights the dynamic nature of nanoparticle surfaces when exposed to water. Surface coatings, intended to stabilize and functionalize the particles, are not static but rather respond to the surrounding aqueous environment. This reshaping can alter the nanoparticle’s ability to bind to target cells or release its drug cargo. Understanding these interactions is crucial for designing more effective drug delivery systems.
Researchers are employing a variety of coating and functionalization strategies to optimize nanoparticle performance. These include modifying the surface with polymers, lipids, or targeting ligands – molecules that specifically bind to receptors on target cells. The goal is to create nanoparticles that are both biocompatible and capable of delivering their therapeutic payload with precision.
Photodynamic therapy, a treatment that uses light-activated drugs to kill cancer cells, is also benefiting from advances in nanoparticle technology. Encapsulating photosensitizers – the light-activated drugs – within nanoparticles can enhance drug retention within tumor tissues and improve treatment specificity, reducing damage to healthy cells.
Despite significant progress, challenges remain in translating nanoparticle-based drug delivery systems from the laboratory to clinical applications. Further research is needed to fully understand the long-term effects of nanoparticle exposure and to develop scalable manufacturing processes that ensure consistent product quality. The Faculty of Pharmacy at Van Lang University in Ho Chi Minh City, Vietnam, and HUTECH University are among the institutions actively engaged in this research.
